Skip to main content

Erosive Esophagitis News

FDA Approves Voquezna for Erosive Esophagitis, GERD

TUESDAY, Nov. 7, 2023 – The U.S. Food and Drug Administration has approved Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of...

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults

FLORHAM PARK, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) – Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

omeprazole, pantoprazole, Nexium, Pepcid, Prilosec, famotidine, Protonix, Tums, lansoprazole, Dexilant, Pepcid AC, Zantac